Huberman Lab
Huberman Lab
June 4, 2026

Essentials: Psychedelics & Neurostimulation for Brain Rewiring | Dr. Nolan Williams

YouTube · GkG1hMhIQ_Q

Quick Read

Dr. Nolan Williams discusses groundbreaking neurostimulation and psychedelic therapies that are rapidly recalibrating brain circuits to treat severe depression, PTSD, and moral injury.
Depression is a circuit problem, not a chemical imbalance, treatable by directly recalibrating brain regions.
Rapid TMS protocols (SAINT) can achieve full depression remission in 1-5 days by 'cramming' brain stimulation.
Psychedelics like MDMA, psilocybin, ibogaine, and ayahuasca offer profound, long-lasting therapeutic effects for PTSD, depression, and moral injury by inducing brain plasticity.

Summary

Dr. Nolan Williams, a neurologist and psychiatrist, outlines a paradigm shift in understanding and treating severe mental health conditions like depression and PTSD. He explains how Transcranial Magnetic Stimulation (TMS), specifically the Stanford Neuromodulation Therapy (SAINT) protocol, can rapidly induce remission in depression by recalibrating brain circuits, moving beyond the outdated 'chemical imbalance' theory of SSRIs. Williams also details the therapeutic potential of psychedelics such as MDMA for PTSD, psilocybin for depression, ibogaine for moral injury in veterans, and ayahuasca for reducing recidivism, emphasizing their ability to create highly plastic brain states that allow for new perspectives on old problems. He stresses the importance of these powerful substances being used strictly in controlled clinical settings, not recreationally, due to their profound effects on consciousness and brain function.
This episode highlights a critical shift in psychiatry from symptom management to direct brain circuit recalibration, offering rapid and durable relief for debilitating mental health conditions. It provides a scientific framework for understanding how neurostimulation and psychedelics can fundamentally 'rewire' the brain, empowering patients with the knowledge that their conditions are treatable and not permanent, challenging long-held stigmas and offering new hope for recovery.

Takeaways

  • Depression is the most disabling condition worldwide and a major risk factor for other illnesses, including coronary artery disease.
  • Transcranial Magnetic Stimulation (TMS) can rapidly restore the prefrontal cortex's governance over deeper emotional brain regions in depression, analogous to a coach directing players.
  • The 'chemical imbalance' theory of depression, often associated with SSRIs, is largely outdated; current understanding points to brain circuit dysfunction.
  • The Stanford Neuromodulation Therapy (SAINT) protocol delivers 7.5 months worth of TMS in 5 days, achieving 60-90% remission rates for severe depression.
  • Psychedelics like MDMA and psilocybin induce brain plasticity and connectivity changes in similar regions as TMS, leading to sustained therapeutic effects for PTSD and depression.
  • Ibogaine, a long-acting psychedelic, facilitates a 'life review' allowing individuals, particularly veterans with moral injury, to re-experience memories with detached empathy and achieve self-forgiveness.
  • Ayahuasca has shown promise in reducing recidivism rates in prisoners, suggesting an impact on behaviors driving criminal activity.
  • Psychedelics are powerful tools for therapeutic change and should be used under strict medical supervision, not for recreational purposes.

Insights

1Depression as a Global Health Risk and Brain Circuit Dysfunction

Depression is recognized as the most disabling condition globally and a significant risk factor for other medical illnesses, including coronary artery disease. Dr. Williams emphasizes that depression is not merely a 'chemical imbalance' but rather a problem of brain circuit dysfunction where deeper emotional regions override the prefrontal cortex's control. This understanding shifts the focus to direct circuit recalibration as a treatment strategy.

The American Heart Association added depression as the fourth major risk factor for coronary artery disease. TMS studies show direct manipulation of brain-heart connections and restoration of prefrontal cortex governance over regions like the anterior cingulate.

2Rapid Depression Remission via Stanford Neuromodulation Therapy (SAINT)

The SAINT protocol (formerly Stanford Accelerated Intelligent Neuromodulation Therapy) is a rapid, high-dose TMS approach that delivers 7.5 months' worth of stimulation in just five days. By applying 'space learning theory' to brain stimulation, it targets the dorsal lateral prefrontal cortex every hour for 10 hours daily, leading to 60-90% remission rates for severe depression within 1-5 days. This approach bypasses the slow action and 'chemical imbalance' assumptions of SSRIs.

Patients receiving SAINT often report full remission within days, with some experiencing sustained relief for years. The mechanism involves restoring the prefrontal cortex's control over deeper emotional regions, which is correlated with treatment improvement.

3Psychedelics Induce Brain Plasticity for Therapeutic Rewiring

Psychedelics like psilocybin, MDMA, ibogaine, and ayahuasca, despite varying mechanisms, all appear to induce profound brain plasticity and alter connectivity, particularly in regions like the subgenual anterior cingulate and default mode network. This allows individuals to re-experience and reconsolidate traumatic memories or negative self-perceptions from a new, detached perspective, leading to long-lasting therapeutic effects for conditions such as PTSD, depression, and moral injury.

Neuroimaging studies with psilocybin show a decrease in overall brain activity but an increase in global connectivity, specifically unpairing the negatively valenced mood system from the self-representation. MDMA trials for PTSD show two-thirds of participants achieving clinically significant improvement lasting for years. Ibogaine facilitates a 'life review' where veterans with moral injury report self-forgiveness.

4MDMA for PTSD and Ibogaine for Moral Injury

MDMA, when administered in a clinical setting, has shown significant and lasting anti-PTSD effects, with roughly two-thirds of patients experiencing substantial relief that can endure for years. Ibogaine, a potent and long-acting psychedelic, is being studied for its ability to help special operations forces veterans process 'moral injury'—trauma from ethically compromising actions—by enabling a detached, empathetic re-examination of past events, leading to self-forgiveness.

Published MDMA trials in Nature Medicine report significant PTSD improvement. Preliminary data from ibogaine studies with special forces individuals indicate dramatic improvements in clinical scales and self-reported forgiveness.

5Ayahuasca's Complex Neurochemistry and Impact on Recidivism

Ayahuasca is a unique two-plant psychedelic brew where one plant provides DMT (dimethyltryptamine) and the other a reversible monoamine oxidase inhibitor (MAOI). This MAOI prevents the breakdown of DMT, allowing it to cross the blood-brain barrier and produce profound psychedelic effects. This ancient combination, discovered by Amazonian practitioners, is remarkably precise. Studies in Brazil have shown that a single ayahuasca session can statistically significantly reduce recidivism rates in prisoners.

The specific combination of plants and preparation method allows DMT to become orally bioavailable. Brazilian studies demonstrated a statistically significant reduction in return-to-prison rates for individuals who underwent an ayahuasca session compared to a control group.

Bottom Line

Some patients undergoing rapid TMS (SAINT) for depression, once in remission, spontaneously report experiencing profound, mindful 'present moment' states, similar to those described in mindfulness practices, even without prior instruction or expectation.

So What?

This suggests that effective brain circuit recalibration for depression might not only alleviate negative symptoms but also unlock enhanced cognitive or experiential states, potentially improving overall well-being beyond baseline mood.

Impact

Further research could explore if specific TMS protocols or combinations with other therapies could intentionally cultivate or sustain these mindful states, offering new avenues for mental enhancement or resilience building.

The indigenous discovery of ayahuasca's two-plant combination, which precisely allows oral DMT to cross the blood-brain barrier via a reversible MAOI, is an extraordinary feat of ancient ethnobotany, given the vast number of plant species and the complexity of the biochemical interaction.

So What?

This highlights a deep, empirical understanding of neurochemistry developed without modern scientific tools, suggesting that traditional knowledge systems may hold other undiscovered therapeutic 'sweet spots' in nature.

Impact

Modern pharmacology could systematically investigate other traditional plant combinations for novel therapeutic compounds or synergistic effects, potentially accelerating drug discovery for complex conditions.

Key Concepts

Psychiatry 3.0: Circuit-Based Approach

This model posits that psychiatric illnesses like depression are fundamentally problems of brain circuit dysfunction, rather than chemical imbalances or solely psychological issues. Treatments like TMS and psychedelics work by recalibrating these circuits, restoring proper communication and function, making conditions 'fixable' like a broken leg or heart arrhythmia.

Space Learning Theory (for Brain Stimulation)

Adapted from cognitive science, this theory suggests that distributing learning or stimulation over time with optimal spacing (e.g., every hour to 90 minutes) maximizes retention and efficacy. The SAINT protocol applies this by delivering multiple TMS sessions daily over five days, 'cramming' the therapeutic signal to rapidly 'teach' the brain to restore healthy function.

Lessons

  • If struggling with severe depression, research advanced neurostimulation therapies like SAINT (Stanford Neuromodulation Therapy) as a potentially rapid and effective alternative to traditional antidepressants.
  • Educate yourself on the scientific basis of psychedelic-assisted therapy for conditions like PTSD and depression, understanding that these are circuit-level interventions and not recreational drugs.
  • Challenge the 'chemical imbalance' narrative of mental illness; recognize that modern psychiatry views conditions like depression as brain circuit dysfunctions that are correctable, fostering a sense of hope and agency in recovery.

SAINT Protocol for Rapid Depression Remission

1

**Targeted Stimulation:** Identify the specific brain region (dorsal lateral prefrontal cortex) involved in mood regulation and its connections to deeper emotional centers.

2

**Intensified Dosing:** Administer a significantly higher total dose of TMS compared to traditional protocols, equivalent to 7.5 months of treatment.

3

**Spaced Learning Application:** Deliver the stimulation in a dense, spaced manner—multiple sessions per day (e.g., every hour for 10 hours) over a short period (5 consecutive days)—to optimize brain plasticity and learning.

4

**Monitor for Remission:** Observe for rapid clinical remission, often occurring within 1 to 5 days, characterized by a return to normal mood levels.

5

**Sustained Care:** Develop strategies for maintenance dosing or ongoing support to ensure the durability of remission, as individual responses vary.

Notable Moments

Patients in remission from SAINT TMS report spontaneous, profound 'present moment' mindfulness experiences, despite never having practiced mindfulness before.

This anecdote suggests that restoring healthy brain function can unlock enhanced states of consciousness and well-being, indicating a potential for 'supra-normal' effects beyond just symptom alleviation.

Veterans with moral injury, after ibogaine sessions, report forgiving themselves for past actions, even those involving accidental civilian casualties.

This highlights ibogaine's unique capacity to facilitate deep psychological processing and emotional healing for complex trauma, demonstrating a powerful potential for addressing profound guilt and self-blame.

Quotes

"

"In depression, the deeper regions govern the prefrontal cortex. In one case, it's like the coach telling the player what to do and in the other case it's like a player telling the coach what to do and you you restore order to the game."

Dr. Nolan Williams
"

"This idea that this chemical imbalance idea is wrong. I really think that part's important because I think that what I'll call psychiatry 1.0, right? this kind of idea of Freud and and psychotherapy and its and its origins. Um, it was a lot around, you know, the your family and those experiences... We've transitioned from that to to the you know for a long time the chemical imbalance which I'll call psychiatry 2.0. You know this idea that there's something chemically missing. The trouble there for a patient right is that it's telling it's sending a message of there's something missing with me."

Dr. Nolan Williams
"

"If you can kind of rid yourself of all those socio-cultural constructions and then re-examine this, these if we just discovered these today, we would say that these sorts of drugs are a huge breakthrough in psychiatry because they allow for us to do a lot of the sorts of things we've been thinking about with with SSRIs, with psychotherapy, but kind of combined, right?"

Dr. Nolan Williams
"

"If you need a prescription for an SSRI, which doesn't change your consciousness a whole lot, and we we're very worried about that and the doctor has to evaluate you for that every week, that the idea that some of these substances would would go outside of of very strict medical supervision is uh is kind of preposterous, actually."

Dr. Nolan Williams

Q&A

Recent Questions

Related Episodes